Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription 05.07.2021 8 Ann Surg Oncol 3 BMC Cancer 3 Br J Cancer 1 Cancer Lett 3 Dis Colon Rectum 2 Gastroenterology 1 Gut 2 Int J Cancer 1 Int J Colorectal Dis 1 J Surg Oncol 1 Lancet Oncol 1 Oncogene 1 Oncol Rep 4 PLoS One 4 World J Surg

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. HUISMAN JF, Schoenaker IJH, Brohet RM, de Vos Tot Nederveen Cappel WH, et al
   Reply to "Intensifying Neoadjuvant Therapy for Rectal Cancers Towards Watchful Waiting," by Chakrabarti, Deep, et al.
   Ann Surg Oncol. 2021;28:4064-4065.
   PubMed        
   
   
2. LI YJ, Yang CN, Kuo YP, Lai WT, et al
   ASO Author Reflections: ATMIN Altering the WNT Signaling Pathway via PARP1 in MSI-High Colorectal Cancer.
   Ann Surg Oncol. 2021 Jul 1. pii: 10.1245/s10434-021-10391.
   PubMed        
   
   
3. MOR E, Laks S, Nissan A, Adileh M, et al
   ASO Author Reflections: Pathologic Response Ratio (PRR) in CRS and HIPEC for Peritoneal Metastasis from Colorectal Cancer.
   Ann Surg Oncol. 2021 Jun 27. pii: 10.1245/s10434-021-10369.
   PubMed        
   
   
4. TAKAHASHI H, Takemasa I, Miyoshi N, Uemura M, et al
   ASO Visual Abstract: Application of Local Hyaluronic Acid Injection in Transanal Minimally Invasive Surgery for Anterior Rectal GIST.
   Ann Surg Oncol. 2021;28:3775-3776.
   PubMed        
   
   
5. TAKAHASHI H, Takemasa I, Doki Y, Eguchi H, et al
   ASO Author Reflections: Opening up the Future with Transanal Minimally Invasive Surgery of Fine Techniques.
   Ann Surg Oncol. 2021;28:3777-3778.
   PubMed        
   
   
6. CHAKRABARTI D, Akhtar N, Rajan S, Qayoom S, et al
   Intensifying Neoadjuvant Therapy for Rectal Cancers Towards Watchful Waiting.
   Ann Surg Oncol. 2021;28:4062-4063.
   PubMed        
   
   
7. TAKAHASHI H, Takemasa I, Miyoshi N, Uemura M, et al
   Application of Local Hyaluronic Acid Injection in Transanal Minimally Invasive Surgery for Anterior Rectal GIST.
   Ann Surg Oncol. 2021;28:3774.
   PubMed        
   
   
8. BHATT A, Kepenekian V, Benzerdjeb N, Glehen O, et al
   ASO Author Reflections: Potential Therapeutic Implications and Prediction of Pathological Complete Response to Systemic Chemotherapy in Colorectal Peritoneal Metastases.
   Ann Surg Oncol. 2021;28:3850-3851.
   PubMed        
   
   

   
   BMC Cancer

9. LAMBERT P, Pitz M, Singh H, Decker K, et al
   Evaluation of algorithms using administrative health and structured electronic medical record data to determine breast and colorectal cancer recurrence in a Canadian province : Using algorithms to determine breast and colorectal cancer recurrence.
   BMC Cancer. 2021;21:763.
   PubMed         Abstract available
   
   
10. WANG S, Pang L, Liu Z, Meng X, et al
    SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target.
    BMC Cancer. 2021;21:767.
    PubMed         Abstract available
    
    
11. NILSSEN Y, Eriksen MT, Guren MG, Moller B, et al
    Factors associated with emergency-onset diagnosis, time to treatment and type of treatment in colorectal cancer patients in Norway.
    BMC Cancer. 2021;21:757.
    PubMed         Abstract available
    
    

    
    Br J Cancer

12. LEE KH, Chen WS, Jiang JK, Yang SH, et al
    The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.
    Br J Cancer. 2021 Jun 29. pii: 10.1038/s41416-021-01470.
    PubMed         Abstract available
    
    
13. LIN M, Fang Y, Li Z, Li Y, et al
    S100P contributes to promoter demethylation and transcriptional activation of SLC2A5 to promote metastasis in colorectal cancer.
    Br J Cancer. 2021 Jun 29. pii: 10.1038/s41416-021-01306.
    PubMed         Abstract available
    
    
14. GUO F, De Brabander I, Francart J, Candeur M, et al
    Correction: Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme.
    Br J Cancer. 2021 Jun 28. pii: 10.1038/s41416-021-01468.
    PubMed        
    
    

    
    Cancer Lett

15. ZHANG H, Chi J, Hu J, Ji T, et al
    Intracellular AGR2 transduces PGE2 stimuli to promote epithelial-mesenchymal transition and metastasis of colorectal cancer.
    Cancer Lett. 2021 Jun 30. pii: S0304-3835(21)00310.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

16. AFFI KOPROWSKI M, Lu KC
    Colorectal Cancer Screening and Postpolypectomy Surveillance.
    Dis Colon Rectum. 2021;64:932-935.
    PubMed         Abstract available
    
    
17. OLSSON LM, Lindmark GE, Israelsson ACE, Korkocic D, et al
    CEACAM5, KLK6, SLC35D3, POSTN and MUC2 mRNA Analysis Improves Detection and Allows Characterization of Tumor Cells In Lymph Nodes Of Colon Cancer Patients.
    Dis Colon Rectum. 2021 Jun 23. pii: 00003453-900000000-99432.
    PubMed         Abstract available
    
    
18. ROSS HM
    Expert Commentary on Colorectal Cancer Screening and Postpolypectomy Surveillance.
    Dis Colon Rectum. 2021;64:936.
    PubMed        
    
    

    
    Gastroenterology

19. BORTOLOMEAZZI M, Keddar MR, Montorsi L, Acha-Sagredo A, et al
    Immunogenomics of colorectal cancer response to checkpoint blockade: analysis of the KEYNOTE 177 trial and validation cohorts.
    Gastroenterology. 2021 Jun 28. pii: S0016-5085(21)03178.
    PubMed         Abstract available
    
    
20. VENNELAGANTI S, Cuatrecasas M, Vennalaganti P, Kennedy KF, et al
    Interobserver Agreement Among Pathologists in the Differentiation of Sessile Serrated From Hyperplastic Polyps.
    Gastroenterology. 2021;160:452-454.
    PubMed        
    
    

    
    Gut

21. ABRAHAMI D, McDonald EG, Schnitzer ME, Barkun AN, et al
    Proton pump inhibitors and risk of colorectal cancer.
    Gut. 2021 Jul 1. pii: gutjnl-2021-325096. doi: 10.1136/gutjnl-2021-325096.
    PubMed         Abstract available
    
    

    
    Int J Cancer

22. PAPADIMITRIOU N, Gunter MJ, Murphy N, Gicquiau A, et al
    Circulating tryptophan metabolites and risk of colon cancer: results from case-control and prospective cohort studies.
    Int J Cancer. 2021 Jul 1. doi: 10.1002/ijc.33725.
    PubMed         Abstract available
    
    
23. CHENG CY, Datzmann T, Hernandez D, Schmitt J, et al
    Do certified cancer centers provide more cost-effective care? A health economic analysis of colon cancer care in Germany using administrative data.
    Int J Cancer. 2021 Jul 2. doi: 10.1002/ijc.33728.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

24. LANG-SCHWARZ C, Melcher B, Hartmann A, Bertz S, et al
    Programmed death ligand 1 (PD-L1) in colon cancer and its interaction with budding and tumor-infiltrating lymphocytes (TILs) as tumor-host antagonists.
    Int J Colorectal Dis. 2021 Jun 25. pii: 10.1007/s00384-021-03985.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

25. DIAZ A, Dalmacy D, Hyer JM, Tsilimigras D, et al
    Intersection of social vulnerability and residential diversity: Postoperative outcomes following resection of lung and colon cancer.
    J Surg Oncol. 2021 Jul 1. doi: 10.1002/jso.26588.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

26. MISKOVIC D, Mirnezami R
    Is complete mesocolic excision superior to conventional colectomy for colon cancer?
    Lancet Oncol. 2021;22:917-918.
    PubMed        
    
    

    
    Oncogene

27. SUN L, Patai AV, Hogenson TL, Fernandez-Zapico ME, et al
    Irreversible JNK blockade overcomes PD-L1-mediated resistance to chemotherapy in colorectal cancer.
    Oncogene. 2021 Jun 30. pii: 10.1038/s41388-021-01910.
    PubMed         Abstract available
    
    

    
    Oncol Rep

28. KONG C, Fu T
    Value of methylation markers in colorectal cancer (Review).
    Oncol Rep. 2021;46.
    PubMed         Abstract available
    
    

    
    PLoS One

29. IBANEZ-SANZ G, Mila N, Vidal C, Rocamora J, et al
    Positive impact of a faecal-based screening programme on colorectal cancer mortality risk.
    PLoS One. 2021;16:e0253369.
    PubMed         Abstract available
    
    
30. CHAI L, Ni J, Ni X, Zhang N, et al
    Association of CYP24A1 gene polymorphism with colorectal cancer in the Jiamusi population.
    PLoS One. 2021;16:e0253474.
    PubMed         Abstract available
    
    
31. DAI YC, Fang CY, Yang HY, Jian YJ, et al
    The correlation of epithelial-mesenchymal transition-related gene expression and the clinicopathologic features of colorectal cancer patients in Taiwan.
    PLoS One. 2021;16:e0254000.
    PubMed         Abstract available
    
    
32. SPAANDERMAN IT, Peters FS, Jongejan A, Redeker EJW, et al
    Framing the potential of public frameshift peptides as immunotherapy targets in colon cancer.
    PLoS One. 2021;16:e0251630.
    PubMed         Abstract available
    
    

    
    World J Surg

33. GUYTON K, Belogortseva N, Levine Z, Kaiser BD, et al
    Patient Acceptance of Routine Serial Postoperative Endoscopy Following Low Anterior Resection (LAR) and Its Ability to Detect Biomarkers in Anastomotic Lavage Fluid.
    World J Surg. 2021;45:2227-2234.
    PubMed         Abstract available
    
    
34. SUN Y, Chen J, Ye C, Lin H, et al
    Pelvimetric and Nutritional Factors Predicting Surgical Difficulty in Laparoscopic Resection for Rectal Cancer Following Preoperative Chemoradiotherapy.
    World J Surg. 2021;45:2261-2269.
    PubMed         Abstract available
    
    
35. RUNKEL M, Diallo TD, Lang SA, Bamberg F, et al
    The Role of Visceral Obesity, Sarcopenia and Sarcopenic Obesity on Surgical Outcomes After Liver Resections for Colorectal Metastases.
    World J Surg. 2021;45:2218-2226.
    PubMed         Abstract available
    
    
36. TAKEDA Y, Mise Y, Matsumura M, Hasegawa K, et al
    Accuracy of Modern Clinical Risk Score Including RAS Status Changes Based on Whether Patients Received Perioperative Chemotherapy for Colorectal Liver Metastases.
    World J Surg. 2021;45:2176-2184.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: